1. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
   Maria E. Reyes et al, 2020, Frontiers in Immunology CrossRef
2. Updates in pharmacotherapy for non-small cell lung cancer: a focus on emerging tubulin inhibitors
   Simone Nardin et al, 2024, Expert Opinion on Pharmacotherapy CrossRef
3. CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance
   Zhenbo Shi et al, 2022, Cancers CrossRef
4. Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer
   Melani Luque et al, 2021, International Journal of Molecular Sciences CrossRef